Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000874976 | SCV001017237 | likely benign | Ehlers-Danlos syndrome, kyphoscoliotic type 1 | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002320043 | SCV002628446 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2022-04-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome Diagnostics Laboratory, |
RCV001580106 | SCV001809700 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001580106 | SCV001974410 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003908312 | SCV004725865 | likely benign | PLOD1-related disorder | 2019-08-09 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |